This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_UVEAMELANOMA_EXALLC for full statistics.
Melanoma of uvea
CD2_UVEAMELANOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
342 |
4. Check minimum number of eventsNone |
342 |
5. Include endpointsNone |
342 |
6. Filter based on genotype QC (FinnGen only) |
342 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Melanoma of uvea
based on the number of shared cases.
Similar with more cases:
- Melanoma of uvea
- Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 342 | 158 | 184 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 64.02 | 61.76 | 65.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 300
- Matched controls
- 3001
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
+∞
323.0
251
*
XCD10
NOMESCO Finland
Electrophysiological examination of eye
273.1
236.1
219
29
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
+∞
214.1
179
*
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
+∞
212.6
178
*
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
+∞
181.2
155
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
520.8
152.9
140
5
WX140
NOMESCO Finland
Parabulbar anesthesy
51.5
137.0
167
71
XCK10
NOMESCO Finland
Photography of fundus of eye
23.3
112.9
184
191
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
17.6
86.7
152
165
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
79.8
73
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.5
70.9
133
156
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
67.2
62
*
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
57.9
67.0
78
18
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
60.5
56
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
+∞
56.0
52
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
14.9
53.8
95
90
WX002
NOMESCO Finland
Sedation and analgesia
6.8
47.7
155
407
XCW99
NOMESCO Finland
Other investigative procedure of eye
8.2
46.9
121
227
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
+∞
32.9
31
*
ZXA05
NOMESCO Finland
Left side
4.3
29.5
151
572
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
16.8
28.6
46
32
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
25.4
24
*
ZXA00
NOMESCO Finland
Right side
3.8
25.1
153
649
S01ED51
ATC
timolol, combinations; ophthalmic
5.6
21.9
69
151
CH2S4
NOMESCO Finland
Photography of iris
236.4
21.9
22
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.2
21.7
96
301
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
26.6
21.3
29
12
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
21.1
20
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
213.4
19.8
20
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
6.5
19.1
52
94
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
18.9
18
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
18.9
18
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
13.7
18.1
31
25
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
23.6
17.1
24
11
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
12.7
15.9
28
24
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.8
15
*
3779
FHL
Other operations in this group include disc removal
+∞
15.8
15
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
89.8
15.7
17
*
CD2S4
NOMESCO Finland
Photography of eye
84.3
14.7
16
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
14.7
14
*
N02AA05
ATC
oxycodone; systemic
3.2
13.4
83
323
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
13.1
174
1065
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
+∞
12.6
12
*
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
+∞
12.6
12
*
XCD20
NOMESCO Finland
Photoangiography of eye
9.1
12.6
26
31
CDC00
NOMESCO Finland
Enucleation of eye
135.3
12.5
13
*
D31.4
ICD-10 Finland
Benign neoplasm: Ciliary body
135.3
12.5
13
*
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
48.7
12.0
14
*
130
Kela drug reimbursment
Malignant tumour
3.7
12.0
55
171
Z51.5
ICD-10 Finland
Palliative care
4.3
11.9
45
117
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
124.5
11.5
12
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
36.5
11.4
14
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.3
11.1
158
970
180
Kela drug reimbursment
Interferon alfa
62.2
10.7
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
5.7
10.6
30
57
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.5
10
*
H33.2
ICD-10 Finland
Serous retinal detachment
27.0
9.9
13
5
L01AX03
ATC
temozolomide; systemic
27.0
9.9
13
5
S01ED01
ATC
timolol; ophthalmic
4.8
9.8
32
72
H26.2
ICD-10 Finland
Complicated cataract
10.6
9.7
18
18
CA1ME
NOMESCO Finland
Ultrasound oculometry
18.3
9.5
14
8
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
8.4
8
*
C69.20
ICD-10 Finland
Retina
+∞
8.4
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.9
99
555
H33.0
ICD-10 Finland
Retinal detachment with retinal break
5.9
7.8
21
38
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
46.2
7.7
9
*
S01EC01
ATC
acetazolamide; systemic
5.7
7.7
21
39
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
25.7
7.6
10
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
6.8
7.5
18
28
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
7.5
81
422
ZXA10
NOMESCO Finland
Bilateral
2.3
7.5
79
407
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.4
7.5
26
63
A04AA02
ATC
granisetron; systemic, transdermal
3.5
7.5
34
105
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
7.1
25
62
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
7.0
32
100
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
6.5
60
289
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
71.3
6.4
7
*
D31.2
ICD-10 Finland
Benign neoplasm: Retina
71.3
6.4
7
*
A06AH03
ATC
naloxegol; oral
11.4
6.3
11
10
S01EA03
ATC
apraclonidine; ophthalmic
11.4
6.3
11
10
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
11.4
6.3
11
10
C79.41
ICD-10 Finland
Secondary malignant tumor of optic nerve and eye
+∞
6.3
6
*
CH3S4
NOMESCO Finland
Photography of iridocorneal angle
+∞
6.3
6
*
S01FA01
ATC
atropine; ophthalmic
27.3
6.3
8
*
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
5.6
6.2
17
32
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
12.9
6.1
10
8
H35.7
ICD-10 Finland
Separation of retinal layers
10.3
6.1
11
11
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.9
6.1
129
864
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
234
882
6.23
59.68
5.8
3.4
29.4
33.5
u/l
1.28
229
840
18
0
+∞
18.93
1.1
0.0
—
—
—
0
0
14
0
+∞
14.69
1.1
0.0
35.6
—
%
—
14
0
14
0
+∞
14.69
1.0
0.0
8.9
—
%
—
14
0
281
2170
2.65
11.18
14.5
7.6
90.6
79.1
u/l
1.69
271
2014
212
1509
2.07
9.43
10.3
6.5
13.6
11.4
umol/l
0.90
207
1426
19
48
4.13
6.99
4.5
2.9
53.1
57.2
%
0.43
19
48
18
45
4.17
6.71
3.6
2.3
4.2
4.5
e9/l
0.22
18
45
206
1585
1.75
5.90
13.6
8.9
4.1
4.2
e9/l
0.04
184
1394
190
1441
1.72
5.62
8.5
6.9
1.2
1.2
mmol/l
0.41
153
1218
131
909
1.72
5.29
3.0
2.6
53.2
57.0
u/l
0.96
122
834
169
1263
1.67
5.12
7.0
4.8
33.9
35.0
g/l
1.50
154
1174
59
334
1.93
4.62
3.7
4.2
9.1
39.6
ug/l
0.70
47
283
12
30
4.11
4.47
1.2
1.3
—
—
—
0
0
31
139
2.35
4.40
2.6
2.9
19.3
1120.5
u/ml
0.58
26
119
172
1326
1.60
4.37
7.4
6.4
1.2
1.2
mmol/l
0.06
160
1199
19
67
2.94
4.30
1.1
1.3
—
—
—
0
0
130
961
1.57
3.82
6.8
3.2
2.4
2.4
mmol/l
0.06
112
841
8
13
6.27
3.52
4.6
4.1
208.8
223.2
u/l
—
8
13
205
1695
1.52
3.50
5.8
5.5
6.9
6.8
mmol/l
0.23
193
1588
20
83
2.50
3.37
2.6
2.5
1.8
1.6
mg/l
0.38
20
73
227
2555
0.67
2.99
6.2
6.4
41.2
40.8
mmol/mol
0.22
211
2367
245
2707
0.67
2.79
4.9
5.4
2.6
2.6
mmol/l
0.09
229
2462
227
2541
0.68
2.72
3.9
4.3
1.4
1.3
mmol/l
1.43
213
2302
235
2612
0.68
2.69
4.3
4.7
1.4
1.5
mmol/l
0.78
221
2373
239
2634
0.69
2.42
4.5
4.8
4.5
4.5
mmol/l
0.25
222
2417
154
1273
1.38
2.26
4.3
4.2
—
—
—
0
0
48
316
1.60
2.24
3.5
3.6
—
—
—
0
0
54
371
1.54
2.11
6.9
5.5
1.1
1.0
mmol/l
0.97
47
344
8
176
0.44
1.75
1.4
1.8
—
—
—
0
0
8
31
2.62
1.67
1.1
1.2
—
—
—
0
0
247
2655
0.75
1.56
5.0
4.9
6.2
6.1
mmol/l
0.43
226
2399
20
115
1.79
1.56
8.4
3.7
25.9
25.1
mmol/l
0.25
20
107
7
28
2.53
1.46
1.7
1.3
179.1
273.6
u/l
—
7
28
0
37
0.00
1.35
0.0
1.1
—
1.3
—
0
10
0
40
0.00
1.33
0.0
1.1
—
4.3
—
0
17
0
41
0.00
1.32
0.0
1.0
—
—
—
0
0
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
35
246
1.47
1.27
2.0
3.0
269.2
208.5
ng/l
0.26
29
220
29
414
0.67
1.24
1.2
1.3
42.9
9.9
u/ml
0.72
12
151
55
423
1.36
1.22
3.2
2.4
20.8
22.3
%
0.49
49
370
83
678
1.30
1.22
2.7
2.4
—
—
—
0
0
284
2688
1.33
1.20
23.0
16.2
27.6
25.1
mg/l
0.53
246
2152
8
38
2.13
1.19
1.1
1.9
—
—
—
0
0
27
183
1.52
1.17
6.9
3.3
2.4
2.0
mmol/l
0.10
21
134
14
80
1.78
1.14
1.8
1.6
—
—
—
0
0
31
428
0.70
1.12
1.2
1.3
57.2
36.2
iu/ml
0.44
13
146
298
2848
1.36
1.11
18.1
11.1
28.3
25.9
u/l
1.48
289
2740
44
335
1.36
1.05
4.5
3.3
13.9
8.2
umol/l
0.50
37
297
59
730
0.77
1.05
1.9
1.6
20.8
20.8
nmol/l
0.01
54
610
152
1353
1.22
1.05
3.6
4.2
0.0
0.0
estimate
0.00
38
254
5
22
2.29
1.03
1.0
1.0
—
—
—
0
0
125
1093
1.23
1.02
4.0
3.4
—
—
—
0
0
9
48
1.90
1.01
1.0
1.1
—
—
—
0
0
0
30
0.00
0.97
0.0
1.3
—
—
—
0
0
9
52
1.75
0.93
1.2
1.3
—
—
—
0
0
16
102
1.60
0.92
2.2
2.7
—
—
—
0
0
33
246
1.38
0.91
1.6
2.0
2.0
1.6
%
0.74
27
214
182
1667
1.20
0.89
4.3
3.3
90.7
50.2
u/l
2.10
172
1539
69
578
1.24
0.84
5.6
2.9
2.5
2.5
mmol/l
0.77
59
504
230
2433
0.83
0.83
5.2
4.6
1.9
2.0
mu/l
0.62
213
2174
25
181
1.41
0.82
1.6
1.5
—
—
—
0
0
108
1215
0.84
0.79
2.4
2.0
98.3
94.6
pmol/l
0.28
59
632
98
857
1.20
0.79
3.4
3.2
0.6
0.5
e6/l
0.15
83
651
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
80
921
0.83
0.75
5.0
4.4
21.8
21.4
%
0.09
44
455
15
100
1.52
0.74
1.9
1.7
—
—
—
0
0
7
117
0.59
0.69
1.6
1.3
—
—
—
0
0
23
172
1.36
0.65
6.8
8.0
23.2
24.6
mmol/l
0.93
23
172
8
129
0.61
0.65
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
95
1.49
0.65
3.2
2.4
0.3
0.4
u/ml
—
8
48
36
289
1.27
0.64
2.8
3.7
1.4
2.1
mmol/l
0.63
28
235
58
494
1.21
0.62
1.8
1.9
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
15
106
1.43
0.58
2.5
1.9
—
—
—
0
0
0
23
0.00
0.58
0.0
1.0
—
41.4
—
0
12
0
23
0.00
0.58
0.0
1.0
—
526.5
—
0
13
129
1401
0.87
0.57
2.3
2.5
—
—
—
0
0
29
360
0.79
0.56
8.6
8.4
—
—
—
0
0
84
748
1.16
0.55
3.5
4.6
0.0
0.0
estimate
0.50
33
244
68
596
1.18
0.54
4.0
4.1
539.6
246.9
ng/l
0.26
56
495
195
2056
0.88
0.54
4.8
4.1
16.1
13.4
mm/h
1.19
182
1875
13
91
1.45
0.53
1.4
1.3
—
—
—
0
0
59
672
0.85
0.50
3.4
3.0
0.7
0.8
ug/l
0.50
43
445
35
291
1.23
0.49
2.6
3.7
5.6
5.7
kpa
0.38
35
283
27
219
1.25
0.47
2.4
1.7
—
—
—
0
0
8
117
0.68
0.46
1.5
1.5
—
—
—
0
0
13
95
1.38
0.44
4.7
4.2
19.4
32.0
mg/l
—
6
76
13
95
1.38
0.44
4.8
4.2
27.5
135.2
mg/l
—
6
76
7
51
1.38
0.44
1.3
1.4
—
—
—
0
0
7
51
1.38
0.44
1.3
1.4
—
—
—
0
0
5
31
1.62
0.43
2.8
2.3
—
—
—
0
0
50
437
1.17
0.42
17.9
26.1
1.5
1.3
inr
—
7
55
5
33
1.52
0.41
1.0
3.0
3.4
4.3
nmol/l
—
5
33
0
17
0.00
0.40
0.0
2.2
—
—
—
0
0
5
34
1.48
0.40
3.2
3.9
262.0
342.7
umol/l
—
5
29
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
1.0
—
0
12
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
128
1199
1.11
0.38
4.2
4.1
34.2
45.4
ng/l
0.68
96
901
67
608
1.13
0.35
1.9
1.7
1219.5
1234.1
nmol/l
0.05
59
470
55
493
1.14
0.35
2.9
3.1
0.8
2.3
e6/l
2.55
32
284
83
764
1.11
0.34
3.3
2.9
5522.2
8811.8
umol/l
0.26
70
642
191
1986
0.91
0.34
4.5
3.8
15.0
14.9
pmol/l
0.24
176
1752
144
1367
1.09
0.32
4.9
5.6
0.0
0.0
estimate
0.00
36
251
58
636
0.89
0.30
1.7
1.8
505.5
441.9
pmol/l
0.73
51
523
226
2326
0.92
0.30
21.9
17.5
38.8
39.3
%
0.26
151
1567
145
1383
1.08
0.29
3.7
4.2
0.0
0.0
estimate
0.00
38
240
24
279
0.85
0.28
9.2
7.5
1.6
1.4
mmol/l
0.30
24
269
29
253
1.16
0.27
2.1
3.0
4.4
4.3
kpa
0.09
29
244
84
897
0.92
0.26
2.4
2.1
239.3
211.9
u/l
0.12
78
840
5
39
1.29
0.23
1.0
1.5
—
—
—
0
0
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
5
41
1.22
0.22
1.0
1.5
—
—
—
0
0
111
1059
1.07
0.21
3.8
4.5
—
—
—
0
0
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
420.6
—
0
5
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
61.4
—
0
10
0
12
0.00
0.21
0.0
1.0
—
9.6
—
0
12
101
961
1.07
0.21
3.4
3.3
1088.5
1467.5
ng/l
1.00
93
826
39
355
1.11
0.21
1.4
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
25
281
0.88
0.20
1.3
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
39
358
1.10
0.18
1.3
1.9
—
—
—
0
0
10
82
1.23
0.17
1.6
1.4
—
—
—
0
0
44
411
1.08
0.15
6.6
7.1
104.5
103.9
mmol/l
0.52
44
401
287
2838
1.07
0.15
24.7
19.3
4.0
4.0
mmol/l
0.96
278
2764
286
2828
1.07
0.14
24.6
19.2
139.6
139.7
mmol/l
0.06
279
2752
252
2556
0.95
0.14
21.3
15.3
75.1
76.0
ml/min/173m2
0.26
219
2122
15
134
1.12
0.11
1.1
1.2
63.6
169.4
iu/ml
—
5
48
37
349
1.07
0.10
4.9
4.7
32.1
32.0
%
0.03
28
229
295
2928
1.05
0.09
31.8
23.8
132.2
134.6
g/l
1.82
290
2876
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
30
319
0.93
0.09
1.2
1.4
—
—
—
0
0
111
1137
0.96
0.09
5.5
5.1
4.0
2.7
ug/l
0.30
99
1005
76
736
1.04
0.09
2.3
2.1
3.3
3.2
mg/l
0.11
70
636
5
63
0.79
0.08
1.0
1.5
—
—
—
0
0
13
117
1.12
0.08
1.3
2.3
—
—
—
0
0
7
66
1.06
0.08
1.0
1.4
—
—
—
0
0
6
72
0.83
0.07
1.5
1.6
—
—
—
0
0
8
74
1.08
0.07
2.0
1.4
—
—
—
0
0
37
353
1.05
0.07
8.0
9.3
5.2
5.1
kpa
0.24
32
340
37
354
1.05
0.07
7.9
9.4
1.5
1.4
mmol/l
0.06
28
285
10
111
0.90
0.06
2.6
2.3
2068.6
382.0
ug/l
—
10
103
51
526
0.96
0.06
1.3
1.2
0.4
1.4
u/ml
—
10
138
52
533
0.97
0.04
3.0
2.7
1.0
1.1
e6/l
0.04
30
317
25
241
1.04
0.03
2.3
3.1
49.7
61.1
ml/min/173m2
—
9
112
18
188
0.96
0.02
1.4
1.7
—
—
—
0
0
63
621
1.02
0.02
1.9
1.7
1.2
1.4
mg/l
0.36
51
487
62
612
1.02
0.01
3.4
4.8
1.0
1.0
kg/l
0.10
11
92
115
1142
1.01
0.01
2.4
2.2
77.7
77.4
nmol/l
0.04
104
1006
14
142
0.99
0.00
1.2
1.3
—
35.2
—
0
10
13
133
0.98
0.00
1.1
1.2
48.1
152.7
u/ml
2.29
13
125
12
115
1.05
0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
135.2
—
0
6
5
52
0.96
0.00
1.6
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
6
64
0.94
0.00
1.2
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
1.2
—
0
8
7
72
0.97
0.00
1.4
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
8
82
0.98
0.00
5.1
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_UVEAMELANOMA – Melanoma of uvea
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).